| Trial Name: |
Cervical Lesions
|
| Intro: |
This research study is designed to test the drug Celecoxib in the treatment of cervical intraepithelial neoplasia (CIN 3-a precancerous lesion of the cervix). |
| Condition: |
|
| Description: |
This research study is designed to test the drug Celecoxib in the treatment of cervical intraepithelial neoplasia (CIN 3-a precancerous lesion of the cervix). Participants on this study are treated with oral celecoxib instead of having the cervical lesions removed with surgery. This study will test the effectiveness and the safety of the drug in women with CIN 3-a of the cervix. |
| Criteria: |
Participants must be 18 years of age or older and be diagnosed with CIN 3 by cervical biopsy. The biopsy should be done between 2 and 8 weeks before enrollment. Participants will also be screened to make sure they match the study criteria. Participants must have a negative pregnancy test and agree to use an acceptable form of contraception. Participants must agree not to take Non Steroidal Anti-Inflammatory Drugs (NSAIDs) and aspirin during the time they are taking the study medication. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back